key: cord-0957071-08vsaov7
authors: Barker, Harlan; Parkkila, Seppo
title: Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
date: 2020-05-30
journal: bioRxiv
DOI: 10.1101/2020.04.13.038752
sha: 5a6db949319de5be8d7ec119f2a1a6b72c131b69
doc_id: 957071
cord_uid: 08vsaov7

The World Health Organization declared the COVID-19 epidemic a public health emergency of international concern on March 11th, 2020, and the pandemic is rapidly spreading worldwide. COVID-19 is caused by a novel coronavirus SARS-CoV-2, which enters human target cells via angiotensin converting enzyme 2 (ACE2). We used a number of bioinformatics tools to computationally characterize ACE2 by determining its cell-specific expression in trachea, lung, and small intestine, derive its putative functions, and predict transcriptional regulation. The small intestine expressed higher levels of ACE2 than any other organ. The large intestine, kidney and testis showed moderate signals, whereas the signal was weak in the lung. Single cell RNA-Seq data from trachea indicated positive signals along the respiratory tract in key protective cell types including club, goblet, proliferating, and ciliary epithelial cells; while in lung the ratio of ACE2-expressing cells was low in all cell types (<2.6%), but was highest in vascular endothelial and goblet cells. Gene ontology analysis suggested that, besides its classical role in renin-angiotensin system, ACE2 may be functionally associated with angiogenesis/blood vessel morphogenesis. Using a novel tool for the prediction of transcription factor binding sites we identified several putative binding sites within two tissue-specific promoters of the ACE2 gene. Our results also confirmed that age and gender play no significant role in the regulation of ACE2 mRNA expression in the lung. IMPORTANCE Vaccines and new medicines are urgently needed to prevent spread of COVID-19 pandemic, reduce the symptoms, shorten the duration of disease, prevent virus spread in the body, and most importantly to save lives. One of the key drug targets could be angiotensin-converting enzyme 2 (ACE2), which is a crucial receptor for the corona virus (SARS-CoV-2). It is known that SARS coronavirus infections lead to worse outcome in the elderly and in males. Therefore, one aim of the present study was to investigate whether age or sex could contribute to the regulation of ACE2 expression. We also decided to explore the transcriptional regulation of ACE2 gene expression. Since data on ACE2 distribution is still conflicting, we aimed to get a more comprehensive view of the cell types expressing the receptor of SARS-CoV-2. Finally, we studied the coexpression of ACE2 with other genes and explored its putative functions using gene ontology enrichment analysis.

INTRODUCTION membrane fusion events [13] [14] [15] . The critical residues contributing to the receptor-spike protein 78 interaction were first determined for SARS-CoV-1 [16] and recently in three independent studies 79 for SARS- . It has been proposed by biolayer interferometry studies that the receptor-80 binding domains of SARS-CoV-1 and SARS-CoV-2 S proteins bind with comparable affinities to 81 human ACE2 [20] . In contrast, a modelling study suggested that binding of SARS-CoV-2 is 82 stronger [21] , which was convincingly confirmed by structural and biochemical data [17, 18] . 83 The clinical characteristics of COVID-19 infection have recently been described based on data from 84 1,099 patients from mainland China [22] . It was found that the clinical characteristics of COVID-19 85 mimic those of SARS-CoV-1 infection. The most dominant symptoms include fever, cough, 86 fatigue, and sputum production, whereas gastrointestinal symptoms are less common. In laboratory 87 parameters, lymphopenia was detected in 83.2% of patients on admission. According to another 88 recent survey of 278 patients with pneumonia caused by SARS-CoV-2, fever was the most common 89 symptom, followed by cough [23] . Bilateral pneumonia has been detected by computed tomography 90 scans in 67.0% of patients [24] . A recent study from Wuhan, China listed the most common clinical 91 complications determined in critically ill COVID-19 patients [25] . The complications during 92 clinical worsening included acute respiratory distress syndrome and respiratory failure, sepsis, acute 93 cardiac injury, and heart failure. 94 Data on the localization of virus receptors can provide insight into mechanisms of virus entry, tissue 95 tropism, and pathogenesis of the disease. Therefore, it is of particular interest to correlate COVID-96 19 symptoms with the distribution pattern of ACE2. The first studies performed by northern 97 blotting indicated that ACE2 is located in the human heart, kidney, and testis [2] . By 98 immunohistochemistry, the expression of the ACE2 protein was identified in the human lung 99 alveolar epithelial cells (type I and II pneumocytes), enterocytes of the small intestine, the brush 100 border of the renal proximal tubules, and the endothelial cells of arteries and veins and arterial 101 smooth muscle cells in several organs [26] . It was proposed that this distribution pattern of ACE2 102 could explain the tissue tropism of SARS-CoV-1 for the lung, small intestine, and kidney [27] . On 103 the other hand, the symptoms of COVID-19, in contrast to SARS-CoV-1 infection, are not 104 associated to the same extent with the gastrointestinal tract in spite of the high expression of ACE2 105 in the intestinal enterocytes [28] . In COVID-19, diarrhea has been reported in just 3.8% of patients, 106 in contrast to 40-70% in SARS-CoV-1 infection [22, 29] . A recent preprint report indicated diarrhea 107 in 18.1% of 254 COVID-19 patients [30] . 108 There are conflicting reports on the expression of ACE2 in the upper respiratory tract [29] . 109 Hamming and coworkers found that only the basal layer of nonkeratinized airway squamous [32] . Although lymphopenia is a typical feature of SARS [22, 29] , ACE2 is not 114 highly expressed on T or B cells or macrophages in the spleen or lymphoid organs [26] . 115 It is known that both SARS-CoV and SARS-CoV-2 infections lead to worse outcome in the elderly 116 [29, 33] . Therefore, one aim of the present study was to investigate whether age could contribute to 117 the regulation of ACE2 expression. We also decided to explore the transcriptional regulation of 118 ACE2 gene expression using a novel computational tool recently developed by the first author of 119 this article. Notably, data on ACE2 distribution is still conflicting, and thus we aimed to get a more 120 comprehensive view of the cell types expressing the receptor of SARS-CoV-2. Finally, we studied 121 the coexpression of ACE2 with other genes and explored its putative functions using a gene 122 ontology enrichment analysis.

ACE2 is weakly expressed in the lung 125 The first aim of our study was to investigate different human tissues using publicly available 126 datasets for the distribution of ACE2 mRNA and protein. In the FANTOM5 dataset, the highest 127 values for ACE2 mRNA, ranked according to signal intensity, were seen for the small intestine, 128 dura mater, colon, testis, thalamus, and rectum ( Fig. 1 ).

129 Figure 2 shows the expression of ACE2 protein in selected human tissues. Representative example 130 images of the ACE2 immunostaining were prepared from tissue specimens of the Human Protein 131 Atlas database (https://www.proteinatlas.org/). The results indicate a strong signal for ACE2 protein 132 in the brush border of small intestinal enterocytes. In the kidney, prominent immunostaining 133 reactions were present in the epithelial cells of proximal convoluted tubules and Bowman´s capsule.

The seminiferous tubules and interstitial cells of testis also demonstrated strong immunostaining.

No immunoreactions for ACE2 were observed in the lung specimens. Very weak signal, associated 136 with apical membranes, was detected in sporadic ciliary cells of a nasopharyngeal mucosa sample.

Although the evaluation of immunostaining reaction is generally considered semiquantitative at 138 most, the results seem to correlate fairly well with the corresponding mRNA expression levels. The respiratory tract is the main target region that is affected by COVID-19 infection. Bulk Seq data from lung specimens showed low expression levels for ACE2 (Fig. 1) . Therefore, we 143 performed an analysis of single cell RNA-Seq using both human lung and mouse trachea datasets, 144 representing the breadth of the lower respiratory tract. Figures 3 and 4 show the expression of 145 ACE2 mRNA in identified cell types of lung and trachea, respectively. In lung, ACE-2 expressing 146 cells are generally uncommon with no cell type having a ratio of ACE2-expressing cells greater 147 than 2.6%. The cell types with the greatest proportion of ACE2 expression are those of arterial 148 vascular endothelial cells (2.55%), goblet cells (2.02%), and venous vascular endothelial cells 149 (1.33%). In trachea, the highest ratio of ACE2-expressing cells included the club cells (16.62%), 150 goblet cells (13.84%), and ciliary epithelial cells (6.63%).

Since both the airways and intestine contain goblet cells, SARS-CoV-1 affects gastrointestinal tract, 152 and bulk RNA-Seq data shows high expression in small intestine and colon, we decided to analyze 153 another single cell RNA-Seq dataset covering mouse intestinal epithelial cells. Since both age and gender may contribute to onset and severity of COVID-19 symptoms we aimed 159 to investigate the effect of these variables on the expression levels of ACE2 mRNA. Figure 6 160 indicates that some tissues showed a slight trend to lower expression in older age categories.

Among all tested tissues, statistically significant differences between the age categories were seen 162 in the tibial nerve (p=8.58 x 10 -6 ), minor salivary gland (p=0.002), aorta (p=0.003), whole blood 163 (p=0.005), transverse colon (p=0.010), hypothalamus (p=0.039), and sun exposed skin (p=0.046).

Importantly, the lung specimens showed no significant difference of ACE2 mRNA expression 165 between different age categories (p=0.681). Complete data on ACE mRNA expression levels in 166 different age categories are shown in Supplementary Table 1. To make a binary comparison of 167 expression by age, samples were divided into groups of ≤45 and >45 years of age. In comparison of 168 these younger and older age groups, significant differences in expression were found in tibial nerve 169 (p=2.47 x 10 -7 ), whole blood (p=3.21 x 10 -4 ), minor salivary gland (p=4.89 x 10 -4 ), sun exposed 170 skin (p=0.003), transverse colon (p=0.022), testis (p=0.025), esophageal muscle layer (p=0.040), 171 and subcutaneous adipose tissue (p=0.045).

ACE2 mRNA levels largely overlapped between male and female sexes as shown in Figure 7 . In 173 the lung, no statistically significant difference was observed in the expression levels between the 174 male and female subjects (p=0.908). Statistically significant differences were observed in the 175 adipose tissue (p=0.0001), whole blood (p=0.0002), amygdala (p=0.0006), transverse colon 176 (p=0.0008), muscle layer of esophagus (p=0.002), left ventricle of heart (p=0.005), Epstein-Barr 177 virus-transformed lymphocytes (p=0.015), and esophagus-gastroesophageal junction (p=0.024).

Notably, there was no clear sex-specific trend pointing to one direction in all these cases. ACE which strongly (<-0.7) negatively correlate with ACE2 are ESRRA (kidney) and TCFL72 (kidney).

The lung-specific transcript TSS aligns with the p3@ACE2 FANTOM5 dataset CAGE peak, which 203 indicates that the expression of this transcript is much lower than the intestinal transcript, which 204 corresponds with p1@ACE2 and p2@ACE2 FANTOM5 CAGE peaks. When we initiated the present study, we hypothesized that understanding better the transcriptional 289 regulation of the ACE2 gene might help to explain the peculiar distribution pattern of ACE2 in 290 tissues. Since upregulation of ACE2 would reflect an increased number of SARS-coronavirus 291 receptors on cell surfaces, it could possibly help us to understand the mechanisms why certain 292 patients (males more than females, old more than young, smokers more than non-smokers) are more 293 susceptible for the most detrimental effects of the COVID-19 infection. In our study, the signals for 294 ACE2 mRNA in the lung specimens did not vary much in different age groups nor did they show 295 significant differences between males and females, which is in line with previous findings [40] . 

The regulation of ACE2 expression remains an enigma and there may be multiple factors involved.

There has been concern that the use of ACE inhibitors and angiotensin receptor blockers could 318 increase the expression of ACE2 and increase patient susceptibility to viral host cell entry [54, 55] .

Previous studies have suggested that both ACE inhibitor and angiotensin II receptor type I 320 antagonist therapies increase ACE2 mRNA expression in the rat heart [56] . There has also been 321 some evidence in humans showing increased expression of ACE2 in the heart, brain, and even in Boxplots for tissues of relevance were generated using Matplotlib and Seaborn libraries. individual TFBSs whose score satisfies a genome-wide threshold of α=0.01. Figure 6 . Effect of age on ACE2 mRNA expression levels. Data is extracted from the GTEx dataset 736 as TPM. In these organs, ANOVA revealed significant differences between age categories in tibial 737 nerve (p=8.58 x 10 -6 ), minor salivary gland (p=0.002), and whole blood (p=0.005). In other tissues, 738 the differences did not reach statistical significance. The highest TPM values are seen the small 739 intestine, testis, and kidney. 

Full GO enrichment results for relevant tissues (lung, small intestine, kidney, 223 colon

The preparation and function of the 425 hypertensin-converting enzyme

A novel angiotensin-converting enzyme-related 428 carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

Some properties of carbonic anhydrase, the CO2

Role of 578 HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle 579 cells

Transcription factor HIF1A: downstream targets, associated 581 pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of 582 reporting in scientific literature

Hnf-1beta transcription factor is an early hif-585 1alpha-independent marker of epithelial hypoxia and controls renal repair

588 O2 regulates stem cells through Wnt/beta-catenin signalling

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and 591

Angiotensin Receptor Blockers: What Is the Evidence? JAMA:in press

Focus on Receptors for Coronaviruses with 593

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on 597 cardiac angiotensin-converting enzyme 2

The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: 601 Focus on Angiotensin

Pulmonary Pathology of Early-Phase

COVID-19) Pneumonia in Two Patients With Lung Cancer

A 634 promoter-level mammalian expression atlas

SciPy 1.0: fundamental algorithms for scientific computing in Python

Profiler: a 647 web server for functional enrichment analysis and conversions of gene lists

Consortium GT (2015) Human genomics. The Genotype-Tissue Expression (GTEx) pilot 658 analysis: multitissue gene regulation in humans

GTRD: a database of 660 transcription factor binding sites identified by ChIP-seq experiments

A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. 664

Zerbino DR 673 and Flicek P (2020) Ensembl 2020

Single Cell RNA-seq reveals ectopic and aberrant lung resident cell populations in Idiopathic Pulmonary 677 Fibrosis

A revised airway epithelial hierarchy includes CFTR-expressing ionocytes

A single-cell survey of the small intestinal epithelium

Current best practices in single-cell RNA-seq analysis: a 688 tutorial

Pooling across cells to normalize single-cell RNA 692 sequencing data with many zero counts

Single cell RNA-Seq analysis of different cell types from the lung (human), derived from 712 data from GEO dataset GSE136831 [70]. ACE2 mRNA expression as normalized, batch-corrected 713 counts is shown for comparison in upper panel. The force directed layout plot was computed and 714 visualized in ScanPy [74]. For each cell type the ratio of cells expressing ACE2 is

I (ATI), alveolar type II (ATII), pulmonary neuroendocrine cells (PNEC), smooth muscle cells 717 (SMC), vascular endothelia (VE)

Single cell RNA-Seq analysis of mouse intestinal epithelial cells. Data is from GEO 729 dataset GSE92332 [72]. ACE2 mRNA expression as normalized, batch-corrected counts is shown 730 for comparison in upper panel

For each cell type the ratio of cells expressing ACE2 is presented in addition to a 732 stacked barplot of the relative cell type frequencies in the whole dataset

Effect of gender on ACE2 mRNA expression levels. Data is extracted from the GTEx 744 dataset as TPM. The expression levels in males and females overlap in all tissue categories

Statistically significant differences studied by ANOVA analysis were determined in esophagus-746 gastroesophageal junction (p=0.024) and whole blood (p=0.0002). The ACE2 mRNA expression 747 levels in testis specimens are shown here for comparison

Figure 8. Prediction of transcription factor binding sites in the human ACE2 gene promoter regions 751 of Ensembl transcripts ENST00000252519 and ENST00000427411 using TFBSfootprinter

The results show putative binding sites 753 for several transcription factors which have a strong correlation of expression with ACE2 in colon, 754 kidney, and ileum. The predicted binding sites overlap regions of conservation in mammal species 755 (Ensembl GERP), and cluster within 400 base pairs (bp) of the transcription start site. B) Promoter 756 region of the lung specific ACE2 transcript. The predicted binding sites cluster within 200 bp of the 757 TSS and overlap regions of conservation in mammal species